Poietis 

Make Tissue Engineering a Reality for Patients

OWNER

Fabien Guillemot (See Profile)


Sector

Personalised medicine

Stage

Development, market readiness, clinical trial

Country

France


Patented Next-Generation Bioprinting platform based on high resolution Laser-Assisted Bioprinting technology

Already available GMP-compliant 3D bioprinter that meets the needs for process standardization & treatment accessibility

Poieskin, autologous dermo-epidermal skin substitute, as one the first 3D bioprinted tissues for implantation, worldwide

High-end bioprinters for translational research already commercialized

A hybrid biotech-medtech organization to partner with ATMP developers

Status

Approved

IP Type

Patent

Time

15 years

Countries

Belgium
Canada
China
France
Germany
Israel
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Our portfolio of 13 patent families (22 patents granted and 53 other applications) provide a strong protection for commercializing Bioprinting systems and for manufacturing living tissues. Main patents cover combination of Laser-Assisted Bioprinting with other bioprinting technologies, robotization of the technology as well as some cartridges dedicated to cell bioprinting.

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: June 20th, 2022

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2022 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar